I have been running oxiracetam for a fortnight and the honest summary is that the effect is smaller than the internet suggests and real.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.
Headache is the classic first-week effect and choline usually sorts it.
Anyone got a paper worth reading on this rather than a write-up of a paper?
Test one thing at a time. It feels slower and it is the only way to learn anything.
Read methods.
What is the first thing you would read if you were starting from zero? Currently on oxiracetam myself.
Is a baseline blood test really necessary before starting something like this?
What is the first thing you would read if you were starting from zero?
An inconclusive account is useful if it stops the next person mistaking a story for a controlled comparison.
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid. Currently on oxiracetam myself.
Baseline first.
A certificate of analysis answers one question and gets quoted as though it answers four. Headaches was my main issue with oxiracetam too.
Test one thing at a time. It feels slower and it is the only way to learn anything.
Read methods.
What is the first thing you would read if you were starting from zero?
Test one thing at a time. It feels slower and it is the only way to learn anything.
How long before you can reasonably say something is or is not doing anything?